Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue.
Progesterone receptor was measured in eight samples of renal cell carcinoma, nine samples of normal renal tissue, and one sample of melanoma tissue. Progesterone receptor was identified in all samples, with the exception of one renal cell carcinoma. Three patients, all with receptor-positive tumors, were treated with medroxyprogesterone acetate for metastatic disease. In one of these patients there was a partial objective response to treatment. Further research regarding progesterone receptor in renal cell carcinoma is indicated.
D000230:Adenocarcinoma / Q000032:analysis* / Q000188:drug therapy / Q000601:surgery; D005260:Female; D006801:Humans; D007668:Kidney / Q000032:analysis* / Q000601:surgery; D007680:Kidney Neoplasms / Q000032:analysis* / Q000188:drug therapy / Q000601:surgery; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008545:Melanoma / Q000556:secondary / Q000601:surgery; D009392:Nephrectomy; D011980:Receptors, Progesterone / Q000032:analysis*; D014625:Vaginal Neoplasms / Q000556:secondary / Q000601:surgery
D011980:Receptors, Progesterone; D008525:Medroxyprogesterone